Bristol-Myers Squibb (BMY) Misses Q4 EPS by 4c; Guides Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results
January 26, 2017 6:59 AM ESTIncreases Fourth Quarter Revenues 22% to $5.2 Billion, 17% for Full Year to $19.4 Billion Posts Fourth Quarter GAAP EPS of $0.53 and Non-GAAP EPS of $0.63 Announces Settlement and License Agreement to Resolve PD-1 Patent Litigation Against Merck Achieves Important Regulatory Milestones for Opdivo Approved in the U.S. for Metastatic Squamous Cell Carcinoma of the Head and Neck Approved in Europe for Classical Hodgkin Lymphoma Completes Strategic Transactions in Oncology and Fibrosis... More
